Clinical Trials Logo

Benign Neoplasms clinical trials

View clinical trials related to Benign Neoplasms.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03042884 Completed - Clinical trials for Malignant Neoplasms of Independent (Primary) Multiple Sites

Wearable Exercise Trackers in Cancer Rehabilitation

Start date: February 13, 2017
Phase: N/A
Study type: Interventional

The goal of this research study is to learn how useful a wearable exercise tracker watch is to monitor your physical activity. This is an investigational study. Up to 100 participants will be enrolled in this study. All will take part at MD Anderson.

NCT ID: NCT02810431 Completed - Cancer Clinical Trials

Long Term Retention of Protspectively Obtained Biospecimens

Start date: December 22, 2011
Phase:
Study type: Observational

Background: This protocol is designed to have samples from closing protocols transferred to this protocol for long-term storage. The protocol is concerned with the retention of blood, plasma, serum, CSF, aspirates, bone marrow, ascites fluid, urine, saliva, PBMCs, skin, mucosal, tumor and healthy tissue samples from patients with cancer to support basic science and clinical research activities of the Medical Oncology Branch and other intramural Laboratories and Branches at the NIH Clinical Research Center and Center for Cancer Research. Objectives: To allow long-term storage of biospecimens collected during prospective clinical trials in patients with various cancer phenotypes, as needed to support the research activities of the Medical Oncology Branch and other Laboratories and Branches. Eligibility: Samples eligible for long-term retention must be from those who have signed consent for storage and retention of biospecimens. Design: Acquired samples will be barcoded and associated data will be entered into an encrypted computer software system, and securely maintained to protect patient identifiers. Samples are retained and made available to the original PI, or other Investigators with the original PI's permission, following submission and approval of a supplemental research protocol to the IRB or OHSRP.

NCT ID: NCT00299195 Completed - Leukoplakia, Oral Clinical Trials

A Randomized Study of Sulindac in Oral Premalignant Lesions

Start date: February 23, 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to see if a drug called sulindac can prevent the development of changes in the mouth that are related to oral pre-cancer growths (oral epithelial dysplasia) or oral cancer. Sulindac is an anti-inflammatory drug that has already been tested in people with arthritis (inflammation of a joint). This study is being done by Memorial Sloan-Kettering Cancer Center in New York, Amrita Institute of Medical Sciences and Research Center in Cochin, India, and Regional Cancer Centre (RCC) in Trivandrum, India.